Results 201 to 210 of about 143,948 (293)

Prostatitis syndromes and benign prostatic hyperplasia

open access: hybrid, 1999
Steven R. Potter, Alan W. Partin
openalex   +1 more source

Pathology of benign prostatic hyperplasia [PDF]

open access: bronze, 2000
Christopher S. Foster
openalex   +1 more source

The evolving role of positron emission tomography in precision prostate cancer biopsy

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 8, August 2025.
Prostate biopsy plays a pivotal role in the detection and characterization of prostate cancer. PSMA PET‐targeted biopsy represents a significant advancement in prostate cancer diagnostics, offering higher sensitivity, specificity and accuracy in detecting clinically significant lesions compared to traditional methods. PSMA PET, when combined with mpMRI,
Alessio Imperiale   +11 more
wiley   +1 more source

To Rezūm or Not to Rezūm: A Narrative Review of Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia. [PDF]

open access: yesJ Clin Med
Kaltsas A   +9 more
europepmc   +1 more source

Is Canine Prostate-Specific Esterase a Reliable Marker for Benign Prostatic Hyperplasia Progression in Dogs? [PDF]

open access: yesAnimals (Basel)
Posastiuc FP   +6 more
europepmc   +1 more source

A deep learning derived prostate zonal volume‐based biomarker from T2‐weighted MRI to distinguish between prostate cancer and benign prostatic hyperplasia [PDF]

open access: yesMed Phys
Abstract Background Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) share overlapping characteristics on magnetic resonance imaging (MRI), confounding the diagnosis and detection of PCa. There is thus a clinical need to accurately differentiate BPH‐Only from BPH‐PCa to prevent overdiagnosis and unnecessary biopsies.
Zhang Z   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy